Results 141 to 150 of about 636,928 (222)

Development of improved pertussis vaccine

Human Vaccines & Immunotherapeutics, 2014
M. Rumbo, D. Hozbor
semanticscholar   +1 more source

Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999-2015. [PDF]

J Pediatric Infect Dis Soc, 2021
europepmc   +1 more source

Acellular pertussis vaccine effectiveness for children during the 2009–2010 pertussis epidemic in Queensland

Medical Journal of Australia, 2014
S. Sheridan, B. McCall, Craig A Davis, J. Robson, B. Hull, C. Selvey, R. Ware, K. Grimwood, Stephen B Lambert   +8 more
semanticscholar   +1 more source

Acellular Pertussis Vaccines

New England Journal of Medicine, 1996
openaire   +3 more sources

COVID-19 in children: Could pertussis vaccine play the protective role? [PDF]

Med Hypotheses, 2020
Ismail MB, Omari SA, Rafei R, Dabboussi F, Hamze M.   +4 more
europepmc   +1 more source

Pertussis vaccine performance in an epidemic year-Oregon, 2012.

Clinical Infectious Diseases, 2014
Juventila Liko, S. Robison, P. Cieslak
semanticscholar   +1 more source

Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study. [PDF]

J Infect Dis
Hermida N, Ferguson M, Leroux-Roels I, Pagnussat S, Yaplee D, Hua N, van den Steen P, Anspach B, Dieussaert I, Kim JH.   +9 more
europepmc   +1 more source

A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine

Mucosal Immunology, 2014
A. Dunne, Lisa A. Mielke, Aideen C. Allen, Caroline E. Sutton, Rowan Higgs, Clare C. Cunningham, Sarah C. Higgins, Kingston H. G. Mills   +7 more
semanticscholar   +1 more source

Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model. [PDF]

J Infect Dis
Kapil P, Wang Y, Zimmerman L, Gaykema M, Merkel TJ.   +4 more
europepmc   +1 more source

Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. [PDF]

PLoS Med
Pérez Chacón G, Estcourt MJ, Totterdell J, Marsh JA, Perrett KP, Campbell DE, Wood N, Gold M, Waddington CS, O' Sullivan M, McAlister S, Curtis N, Jones M, McIntyre PB, Holt PG, Richmond PC, Snelling T.   +16 more
europepmc   +1 more source